• About Gilead
    • Corporate Overview
    • Leadership
    • Worldwide Operations
    • Policy Perspectives
    • Business Conduct
    • Partners and Business Development
  • Products
    • Medical Information Request
    • Patient Care
    • Product Approvals Timeline
  • Research
    • Pipeline
    • Clinical Trials
    • Investigator-Sponsored Research (ISR)
  • Investors
  • Newsroom
    • Press Releases
    • Media Inquiries
    • Policy Perspectives
    • Media FAQ
  • Community
    • U.S. Patient Access
    • Developing World Access
    • Corporate Grants and Giving
  • Careers
    • Current Opportunities
    • Culture
    • U.S. Benefits
   CONTACT    SITE MAP  
   SEARCH
Gilead
 
Investor Fact Sheet
  • Corporate Governance
  • Stock Information
  • Financial Information
    Fundamentals
    Estimates
    Analyst Coverage
    SEC Filings
    Earnings
    Annual Reports
    Proxy Online
    Stockholder E-Delivery
    GAAP to NON-GAAP RECONCILIATION
    Financial Tear Sheet
  • News and Events
  • Email Alerts
  • Financial FAQ
  • Contact Information
Print Page Print Page | E-mail Page E-mail Page | Financial Tear Sheet Financial Tear Sheet
TitleFormat
Q1 2012 Financial Tear Sheet

Get Help Downloading or Viewing The Adobe File Types


Please note that Gilead's Financial Tear Sheet is updated on a quarterly basis. Information contained in this fact sheet provides a summary within the quarter only.

© 2012 Gilead | Terms of Use | Privacy